Tei Mitsuyoshi, Suzuki Yozo, Wakasugi Masaki, Akamatsu Hiroki
Department of Surgery, Osaka Police Hospital, 10-31, Kitayama-cho, Tennoji-ku, Osaka City, Osaka, 543-0035, Japan.
Surg Today. 2017 Jun;47(6):676-682. doi: 10.1007/s00595-016-1425-2. Epub 2016 Oct 3.
To compare the perioperative and short-term oncological outcomes of patients who underwent single-port surgery (SPS) with those of patients who underwent multi-port surgery (MPS) for transverse colon cancer.
The records of consecutive patients who underwent SPS (n = 75) or MPS (n = 41) for transverse colon cancer in our department between January, 2008 and December, 2015 were analyzed retrospectively.
Operative times were significantly shorter in the SPS group than in the MPS group (185 vs. 195 min, respectively; P = 0.043). There were no significant differences in operative procedures, blood loss, or extent of lymph node dissection. The rate of postoperative complications was similar in both groups, but the length of hospital stay was significantly shorter in the single-port group than in the multi-port group (8 vs. 11 days, respectively; P < 0.001). Oncological outcomes were similar in both groups. The disease-free survival rate at 2 years did not differ significantly between the groups (91.1 vs. 94.9 %, respectively; P = 0.414).
Our experience demonstrates that SPS is safe and can provide oncological outcomes equal to those of MPS for transverse colon cancer.
比较接受单孔手术（SPS）与多孔手术（MPS）治疗横结肠癌患者的围手术期及短期肿瘤学结局。
回顾性分析2008年1月至2015年12月期间在我科接受SPS（n = 75）或MPS（n = 41）治疗横结肠癌的连续患者的记录。
SPS组手术时间明显短于MPS组（分别为185分钟和195分钟；P = 0.043）。手术操作、失血量或淋巴结清扫范围无显著差异。两组术后并发症发生率相似，但单孔组住院时间明显短于多孔组（分别为8天和11天；P < 0.001）。两组肿瘤学结局相似。两组2年无病生存率无显著差异（分别为91.1%和94.9%；P = 0.414）。
我们的经验表明，SPS对于横结肠癌是安全的，并且可以提供与MPS相当的肿瘤学结局。
